Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Sector Analysis

Surgical & Medical Instruments & Apparatus

Standard Industrial Classification: SIC 3841

Industry Insider Sentiment Analysis

The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.

Filing Date Trade Date Ticker Company Reporting Person Relationship Type Price Qty Total, $ Owned After
2016-09-01 04:34 2016-08-29 PEN Penumbra Inc Rothman Lynn Officer SELL $71.17 5,300 $377,214 203,406
2016-09-01 04:29 2016-08-29 PEN Penumbra Inc Bose Arani Director, Officer OPT+S $71.15 26,000 $1,850,004 732,191
2016-09-01 00:35 2016-08-29 UTMD UTAH MEDICAL PRODUCTS INC CORNWELL KEVIN L Director, Officer SELL $64.54 2,916 $188,200 255,575
2016-09-01 04:31 2016-08-29 PEN Penumbra Inc Evans Robert D. Officer SELL $71.17 5,300 $377,189 269,396
2016-09-01 00:32 2016-08-29 LMAT LEMAITRE VASCULAR INC Gebauer Peter R Officer OPT+S $17.83 30,246 $539,208 25,374
2016-09-01 00:26 2016-08-30 OSUR ORASURE TECHNOLOGIES INC JERRETT JACK E Officer OPT+S $8.52 68,686 $585,425 48,105
2016-09-01 00:24 2016-08-05 OSUR ORASURE TECHNOLOGIES INC Patrick Charles W Director SELL $8.28 26,308 $217,722 14,905
2016-08-31 01:06 2016-08-29 SYK STRYKER CORP STRYKER RONDA E Director SELL $115.80 12,000 $1,389,628 7,596,233
2016-08-30 17:06 2016-08-23 CMXC Stimcell Energetics Inc. JEFFS RICHARD 10% owner BUY $0.15 10,000 $1,500 2,152,900
2016-08-30 03:56 2016-08-25 PEN Penumbra Inc Bose Arani Director, Officer OPT+S $71.07 26,800 $1,904,641 732,191
2016-08-30 03:53 2016-08-25 PEN Penumbra Inc Elsesser Adam Director, Officer OPT+S $71.06 26,800 $1,904,526 1,235,838
2016-08-30 03:51 2016-08-25 PEN Penumbra Inc Davis Daniel Donen Officer SELL $71.03 5,300 $376,434 67,026
2016-08-30 03:48 2016-08-25 PEN Penumbra Inc Rothman Lynn Officer SELL $71.02 5,300 $376,403 208,706
2016-08-30 03:45 2016-08-25 PEN Penumbra Inc Pray James Robert Officer SELL $71.03 5,300 $376,484 607,347
2016-08-29 17:30 2016-08-25 SYK STRYKER CORP STRYKER RONDA E Director SELL $113.75 12,000 $1,364,952 7,608,233
2016-08-30 03:43 2016-08-25 PEN Penumbra Inc Evans Robert D. Officer SELL $71.03 5,300 $376,448 274,696
2016-08-29 18:52 2016-08-26 BSTG Harvard Apparatus Regenerative Technology, Inc. KENNEDY JOHN F Director BUY $0.93 16,182 $15,033 58,406
2016-08-27 03:08 2016-08-24 ICUI ICU MEDICAL INC/DE Jain Vivek Director, Officer SELL $124.25 7,268 $903,019 48,497
2016-08-26 18:01 2016-08-24 CTSO Cytosorbents Corp Chan Phillip P. Director, Officer BUY $4.89 5,000 $24,450 121,648
2016-08-27 01:36 2016-08-24 DXCM DEXCOM INC GREGG TERRANCE H Director, Officer SELL $92.72 10,000 $927,151 86,622
2016-08-26 23:49 2016-08-24 DXCM DEXCOM INC Balo Andrew K Officer OPT+S $91.72 5,000 $458,600 129,979
2016-08-25 22:10 2016-08-23 PAVM PAVmed Inc. Aklog Lishan Director, Officer, 10% owner BUY $14.22 1,500 $21,323 17,900
2016-08-25 19:05 2016-08-25 BSTG Harvard Apparatus Regenerative Technology, Inc. McGorry James Joseph Director, Officer BUY $0.96 25,000 $24,000 126,300
2016-08-25 23:22 2016-08-23 IART INTEGRA LIFESCIENCES HOLDINGS CORP Murphy Raymond G. Director OPT+S $86.64 2,600 $225,252 30,447
2016-08-25 16:15 2016-08-23 LMAT LEMAITRE VASCULAR INC Roberts David B Director, Officer SELL $17.35 10,000 $173,527 129,793
2016-08-25 23:35 2016-08-23 DXCM DEXCOM INC DOUBLEDAY RICHARD Officer SELL $90.89 3,182 $289,224 31,825
2016-08-25 23:33 2016-08-23 DXCM DEXCOM INC Pacelli Steven Robert Officer SELL $90.74 10,300 $934,588 151,622
2016-08-24 13:05 2016-08-19 DRIO DarioHealth Corp. Raphael Erez Director, Officer BUY $3.57 500 $1,785 111,129
2016-08-25 04:54 2016-08-22 PEN Penumbra Inc Bose Arani Director, Officer OPT+S $72.95 29,000 $2,115,623 732,191
2016-08-25 04:52 2016-08-22 PEN Penumbra Inc Elsesser Adam Director, Officer OPT+S $72.95 29,000 $2,115,646 1,235,838
2016-08-25 04:48 2016-08-22 PEN Penumbra Inc Davis Daniel Donen Officer SELL $72.97 6,300 $459,727 72,326
2016-08-25 04:26 2016-08-22 PEN Penumbra Inc Rothman Lynn Officer SELL $72.99 6,300 $459,806 214,006
2016-08-25 04:22 2016-08-22 PEN Penumbra Inc Pray James Robert Officer SELL $72.97 6,300 $459,680 612,647
2016-08-24 19:32 2016-08-23 SYK STRYKER CORP STRYKER RONDA E Director SELL $113.53 12,000 $1,362,310 7,620,233
2016-08-25 04:19 2016-08-22 PEN Penumbra Inc Evans Robert D. Officer SELL $73.00 6,300 $459,896 279,996
2016-08-25 03:51 2016-08-22 LMAT LEMAITRE VASCULAR INC LeMaitre George W Director, Officer, 10% owner SELL $17.43 35,391 $616,954 3,465,100
2016-08-25 03:07 2016-08-22 DXCM DEXCOM INC GREGG TERRANCE H Director, Officer SELL $90.81 20,000 $1,816,224 96,622
2016-08-24 17:23 2016-08-23 WST WEST PHARMACEUTICAL SERVICES INC Johnson Paula A Director SELL $81.55 3,042 $248,075 38,450
2016-08-25 00:47 2016-08-22 CERS CERUS CORP Green Kevin Dennis Officer OPT+S $6.80 17,150 $116,613 42,167
2016-08-24 03:35 2016-08-19 DXCM DEXCOM INC ALTMAN STEVEN R Director SELL $90.91 3,500 $318,177 15,142
2016-08-22 18:52 2016-08-19 SYK STRYKER CORP STRYKER RONDA E Director SELL $113.82 12,000 $1,365,797 7,632,233
2016-08-23 01:18 2016-08-19 RMD RESMED INC PACE GARY W Director OPT+S $69.93 36,000 $2,517,336 93,158
2016-08-22 16:04 2016-08-19 LMAT LEMAITRE VASCULAR INC LeMaitre Cornelia W Director SELL $17.15 5,000 $85,733 178,319
2016-08-23 04:27 2016-08-19 DXCM DEXCOM INC SKYLER JAY S Director SELL $90.77 25,000 $2,269,233 42,246
2016-08-23 04:26 2016-08-18 DXCM DEXCOM INC GREGG TERRANCE H Director, Officer SELL $90.70 40,000 $3,627,840 116,622
2016-08-19 21:54 2016-08-17 BVX Apyx Medical Corporation McCarthy John J. III Officer BUY $3.30 90,750 $299,475 115,750
2016-08-19 23:13 2016-08-17 HAE HAEMONETICS CORP MERRIMAN RONALD Director SELL $35.14 4,337 $152,398 17,851
2016-08-19 14:44 2016-08-17 SYK STRYKER CORP STRYKER RONDA E Director SELL $113.07 12,000 $1,356,842 7,644,233
2016-08-20 03:20 2016-08-17 CMXC Stimcell Energetics Inc. JEFFS RICHARD 10% owner BUY $0.17 10,250 $1,743 2,142,900
2016-08-18 23:22 2016-08-17 ATRC AtriCure, Inc. Krell Elizabeth D Director OPT+S $15.20 5,000 $76,000 10,162
SHOW ENTRIES

Sector-Wide Insider Alpha

Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.

SEC Filings in Surgical & Medical Instruments & Apparatus

Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.